Agios Pharmaceuticals reported $-1.78 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1.95 -1.44 Feb/12 2026
FY2025Q3 Sep/2025 -1.78 -1.91 16.22 Oct/30 2025
FY2025Q2 Jun/2025 -1.93 -1.85 -1.69 Jul/31 2025
FY2025Q1 Mar/2025 -1.55 -1.76 -1.45 May/01 2025
FY2024Q4 Dec/2024 -1.44 -1.68 -1.72 Feb/13 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD -0.11 1.15 Sep/2025
Astellas Pharma JPY 44.22 6 Sep/2025
AstraZeneca USD 2.38 0.21 Sep/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Exelixis USD 0.78 0.03 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Incyte USD 2.26 0.69 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -0.51 1.62 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025